DKK1 and breast carcinoma: Indeed, a role for DKK1 overexpression in cancer [26], including hepatobastomas [33] and breast cancer bone metastasis [34], aggressive tumors, epithelial-mesenchymal transition [35] and proliferation [36], has been previously suggested, although its precise mechanism of action has not yet been elucidated.